Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets

NCT04899921 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Due to poor enrollment

Conditions

Melanoma
Metastatic Melanoma

Interventions

DRUG: Ipilimumab
DRUG: Nivolumab
DRUG: Troriluzole
DRUG: Placebo

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]